Induction of differentiation and inhibition of DNA methylation in HL-60 myeloid leukemic cells by 5-AZA-2'-deoxycytidine

Leuk Res. 1985;9(11):1361-6. doi: 10.1016/0145-2126(85)90123-7.

Abstract

The effects of 5-AZA-2'-deoxycytidine (5-AZA-CdR) on the induction of morphological and biochemical differentiation and inhibition of DNA methylation of human HL-60 myeloid leukemic cells were investigated. 5-AZA-CdR at concentrations of 0.1-1 microgram ml-1 for 48-h exposure produced significant morphological differentiation of HL-60 leukemic cells to a more mature phenotype, augmented the cell surface marker (OKMI) for mature granulocytes/monocytes and also increased the superoxide anion production. Under these same conditions 5-AZA-CdR inhibited the synthesis of 5-methylcytosine in DNA suggesting that there is a correlation between the induction of differentiation and inhibition of DNA methylation. At concentrations of 5-AZA-CdR that inhibit DNA methylation there was a marked decrease in colony-formation suggesting that the antileukemic action of this analog is related to the methylation of DNA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Azacitidine / analogs & derivatives*
  • Azacitidine / pharmacology
  • Cell Differentiation
  • Cell Line
  • DNA / metabolism*
  • Decitabine
  • Dimethyl Sulfoxide / pharmacology
  • Dose-Response Relationship, Drug
  • Humans
  • Leukemia, Myeloid, Acute / metabolism
  • Leukemia, Myeloid, Acute / pathology*
  • Methylation
  • Superoxides / metabolism

Substances

  • Antineoplastic Agents
  • Superoxides
  • Decitabine
  • DNA
  • Azacitidine
  • Dimethyl Sulfoxide